JUPW's Go-To-Market Plan
Go-To-Market Strategy: Focus on B2B and B2C sales/distribution by following channels:
- MMR: Sales team to continue developing and maintaining relationships with mass merchandise retailers like Walmart, Target, CVS, Walgreens, etc.
- Wholesale: Expand contracted brokers/reps to saturate independent retailers like pharmacies, doctor offices, drug stores, etc.
- E-Comm: Execute shrewd integrated marketing campaigns with a heavy focus on brand awareness to increase website conversions and build customer lifetime value.
- Strategic IP: Focus on licensing formulations worldwide.
JUPW's Growth Plan for New Products
Expand B2B store count and existing shelf space.
Maintain retailer relationships/shelf space as regulation develops.
Increase B2C site visitors with targeted brand awareness campaigns.
Optimize product offering by sales channel.
Focus product innovation on “claims-based” products.
Leverage flagship brand equity with line extensions and cross-merchandising.
Pursue new markets that leverage brands and infrastructure (Licensing opportunities).
Optimize cost structure to increase margins and EBITDA.
In-vest in science/research to support product claims.
Build and maintain relationships with regulators such as the FDA.
Read the full company presentation here.
-----
And as I mentioned above, JUPW has several potential catalysts to familiarize yourself with now. Here they are:
No. 1 JUPW Potential Catalyst - Bullish Technicals Could Be Painting A Breakout Target On JUPW
I'm telling you right now... Don't discount JUPW's bullish technical indicators.
At close on Friday, JUPW was displaying several triggered technical indicators across the short, medium term, and long term.
Barchart was reporting these as triggered:
Short Term Indicators
- 20 Day Moving Average
- 20 - 50 Day MACD Oscillator
- 20 - 100 Day MACD Oscillator
- 20 - 200 Day MACD Oscillator
Medium Term Indicators
- 50 Day Moving Average
- 50 - 100 Day MACD Oscillator
- 50 - 150 Day MACD Oscillator
Long Term Indicators
- 100 Day Moving Average
- 150 Day Moving Average
- 200 Day Moving Average
The website also shares its all-important "TrendSeeker" composite indicator is triggered too.
Watch these technicals closely this week.
-----
No. 2 JUPW Potential Catalyst - Company Subsidiary To Spin Off As Digital Securities Dividend (Added Exposure Expected)
Jupiter Wellness Announces Plan to Spin Off Caring Brands, Inc. as Digital Securities Dividend to Shareholders
Spinoff Dividend Record Date Planned for Late November
JUPITER, FL / ACCESSWIRE / November 7, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW), a wellness company focused on hair loss, eczema, burns, and sexual wellness, announced that it has plans to transfer and spin-off forty percent (40%) of the Company's wholly-owned subsidiary, Caring Brands, Inc., by way of a dividend in the form of digital securities to Jupiter Wellness shareholders with a record date to occur in late November. The Company will maintain sixty percent (60%). The spin-off transaction will be subject to various conditions, including Caring Brands, Inc. meeting the qualifications for future listing on the Block-chain-powered Securities Exchange Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ"). Management's intention is to publicly list Caring Brands, Inc. via a listing on Upstream in December 2022.
Caring Brands, Inc. is an innovative developer of cann-a-bidiol (C-B-D) based therapeutics and wellness products. The Company's inventory of C-B-D-enhanced skin-care therapeutics addresses a range of indications including skincare and general wellness. The Company generates revenue through the manufacturing, distribution, and marketing of a diverse line of consumer products infused with C-B-D.
...
Speaking about the application to list on Upstream, Brian John, CEO of Jupiter Wellness, said, "We are always looking for ways to create greater liquidity and value for our shareholders. We view a dual listing on Upstream as being an excellent way to reach a worldwide market of potential new in-vest-ors who can learn about our Company. We recently announced a business pivot to streamline our business focus and look forward to updating our expanding shareholder base as we move forward."
Approval to be listed on Upstream is subject to acceptance by MERJ including, but not limited to, disclosure, filing, and notification requirements.
Read the full article here.
-----
No. 3 JUPW Potential Catalyst - A Low Float Provides Potential For Volatility
According to the Yahoo Finance website, JUPW has a low float.
The website reports this profile to have approximately 15.86Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility.
Could more positive 2022 company news help provide a near term spark?
-----
No. 4 JUPW Potential Catalyst - Re-opening Of Enrollment In Key Eczema Trial (More Info To Come Early 2023)
Jupiter Wellness Re-Opens Enrollment in Clinical Trial Comparison of JW-100 and EUCRISA for the Treatment of Eczema
Expected to Complete Patient Enrollment of Clinical Trial in December 2022
JUPITER, FL / ACCESSWIRE / November 10, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW), a wellness company focused on hair loss, eczema, burns, and sexual wellness, announced today that it has re-opened enrollment in a clinical trial aimed at evaluating the superiority of JW-100, a novel cann-a-bidiol topical cream, in a head-to-head study against EUCRISA, an FDA Approved topical treatment for eczema developed by Pfizer.
The study was put on hold to solve stability issues in the original JW-100 formulation. These issues were addressed and resolved to the satisfaction of the study's clinical investigators.
Jupiter Wellness CEO, Brian John, said "Due to the nature of a double-blind study, we are only able to access certain data from the first run of this trial. However, what we have seen suggests to our team of scientists that we are on the right track and that this study warrants continuation. We are very encouraged by this update and hope to prove that our JW-100 is as effective, if not superior to a leading drug already on the market that does hundreds of Mn's in revenue. We hope to have the second half of this trial completed in the first quarter of 2023."
Read the full article here.
-----
No. 5 JUPW Potential Catalyst - New Patent Bolsters Company's Growing Position In The Hair Loss Market
Jupiter Wellness Announces Notice of Allowance for Minoxidil Adjuvant Therapies U.S. Patent
JUPITER, FL / ACCESSWIRE / September 28, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair loss, eczema, burns, and sexual wellness announced today that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for patent application No. 16/747,685, titled "Minoxidil Adjuvant Therapies." Jupiter Wellness acquired this case through its recent acquisition of Applied Biology assets.
The patent relates to the composition and methods for inducing (up-regulating) the expression of sulfotransferases in the hair follicles on the scalp. Induction of the sulfotransferase enzyme in hair follicles increases the sulfonation capacity of minoxidil; thus, increasing the response level to oral and topical minoxidil in the treatment of alopecia.
Dr. Glynn Wilson, Chief Scientific Officer said, "This new patent bolsters our growing position in the hair loss market and further protects our continued in-vest-ment in the market. Patents covering compositions and methods provide some of the strongest protections a patent can provide. Through the acquisition of Applied Biology assets and the continued work of our team, we are even more strongly positioned to expand our reach in the global hair loss treatment market."
Jupiter Wellness has licensed the minoxidil adjuvant therapies covered by this patent to Taisho Pharmaceutical Co. Ltd, the largest marketer of minoxidil in Japan.
Read the full article here.
-----
JUPW Recap - 5 Potential Catalysts That Could Paint A Breakout Target
No. 1 - Bullish Technicals Could Be Painting A Breakout Target On JUPW
No. 2 - Company Subsidiary To Spin Off As Digital Securities Dividend (Added Exposure Expected)
No. 3 - A Low Float Provides Potential For Volatility
No. 4 - Re-opening Of Enrollment In Key Eczema Trial (More Info To Come Early 2023)
No. 5 - New Patent Bolsters Company's Growing Position In The Hair Loss Market
-----
Coverage is officially initiated on JUPW. When time permits, do this:
